INSERM U987 and Université de Versailles St.-Quentin-en-Yvelines, Montigny-le-Bretonneux, France, and Université Paris Diderot, Sorbonne Paris Cité, and Laboratoire d'Excellence Inflamex, Paris, France.
Arthritis Rheumatol. 2014 Sep;66(9):2412-22. doi: 10.1002/art.38737.
HLA-B27/human β2 -microglobulin (hβ2 m)-transgenic (B27-transgenic) rats develop an inflammatory disorder resembling spondyloarthritis, with accumulation of proinflammatory Th17 cells. Because Treg cells and Th17 cells have opposing effects in inflammatory disorders, we sought to determine whether biased expansion of Th17 cells could result from altered Treg cell frequency and/or function in B27-transgenic rats.
We characterized the phenotype and function of Treg cells from B27-transgenic rats in comparison with those from control rats, by examining their expression of cell surface markers, suppressive activity, cytokine production, and differentiation pattern.
In B27-transgenic rats, the preferential accumulation of CD4+ Teff cells over Treg cells was not associated with a defect in Treg cell differentiation or suppressive activity. The expression of Treg cell markers was similar between B27-transgenic and control rats, with the exception of the inducible costimulator (ICOS) molecule, which was overexpressed in B27-transgenic rats. High levels of ICOS are considered to be a hallmark of Treg cells with heightened suppressive activity and interleukin-10 (IL-10) expression. Paradoxically, the production of IL-10 by Treg cells was reduced in B27-transgenic rats, whereas the production of IL-17 was enhanced. Moreover, the addition of anti-ICOS monoclonal antibodies during Treg cell differentiation in the presence of dendritic cells from B27-transgenic rats reversed this cytokine profile, restoring the balance between IL-10 and IL-17 in Treg cells from B27-transgenic rats.
We observed dysregulated production of IL-10 and IL-17 by Treg cells from B27-transgenic rats, which may contribute to disease development. Moreover, our data highlight a key role for ICOS signaling in the generation of imbalanced production of IL-10 and IL-17 by Treg cells in this experimental model of spondyloarthritis.
HLA-B27/人β2-微球蛋白(hβ2m)-转基因(B27-转基因)大鼠发展成一种炎症性疾病,类似于脊柱关节炎,伴有促炎 Th17 细胞的积累。因为 Treg 细胞和 Th17 细胞在炎症性疾病中有相反的作用,所以我们试图确定在 B27-转基因大鼠中,Th17 细胞的偏倚扩增是否会导致 Treg 细胞频率和/或功能的改变。
我们通过检查 B27-转基因大鼠和对照大鼠的 Treg 细胞的表面标记物表达、抑制活性、细胞因子产生和分化模式,来比较 B27-转基因大鼠和对照大鼠的 Treg 细胞表型和功能。
在 B27-转基因大鼠中,CD4+Teff 细胞的优先积累与 Treg 细胞的分化或抑制活性缺陷无关。B27-转基因大鼠和对照大鼠的 Treg 细胞标志物表达相似,除了诱导共刺激分子(ICOS),其在 B27-转基因大鼠中过表达。高水平的 ICOS 被认为是 Treg 细胞具有增强的抑制活性和白细胞介素-10(IL-10)表达的标志。矛盾的是,B27-转基因大鼠 Treg 细胞产生的 IL-10 减少,而产生的 IL-17 增加。此外,在 B27-转基因大鼠树突状细胞存在的情况下,在 Treg 细胞分化过程中添加抗 ICOS 单克隆抗体,可逆转这种细胞因子谱,恢复 B27-转基因大鼠 Treg 细胞中 IL-10 和 IL-17 之间的平衡。
我们观察到 B27-转基因大鼠 Treg 细胞产生 IL-10 和 IL-17 的失调,这可能有助于疾病的发展。此外,我们的数据突出了 ICOS 信号在该脊柱关节炎实验模型中 Treg 细胞产生不平衡的 IL-10 和 IL-17 中的关键作用。